While continuous positive airway pressure (CPAP) therapy has a strong evidence base for
the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity …

We who treat sleep disordered breathing and influence the field in a substantial way have
failed to promote the efficacy of nasal CPAP therapy for obstructive sleep apnea syndrome …

The most common first-line therapy for obstructive sleep apnea (OSA) is the use of positive
airway pressure (PAP) devices during sleep. PAP directly relieves upper airway obstruction …

The first-line therapy continuous positive airway pressure (CPAP) was invented in Australia
2 and is highly effective in resolving the repetitive upper airway narrowing and closure that …

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

The recently published technology assessment of continuous positive airway pressure
(CPAP), prepared by the Agency for Healthcare Research and Quality (AHRQ) and entitled …

The practice of sleep medicine is expanding and evolving rapidly, often ahead of the
evidence base to support clinical practice. Obstructive Sleep Disordered Breathing (SDB) is …

Rationale. elderly patients with non-severe Obstructive sleep apnea (OSA) is yet to be
determined. The aim of this study was to analyze the effect of long-term CPAP on the …

We appreciated the article by Rossi et al.[1] entitled “Is continuous positive airway pressure
necessarily an everyday therapy in patients with obstructive sleep apnoea?”, as well as the …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …